Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
University of Texas Southwestern Medical Center · with Stanford University · NCT03906435
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- April 15, 2019
- Record last updated
- July 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.
Being studied: Cognitive Behavioral Therapy
Conditions: Premature Infant; Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse); Development, Child; Parent-Child Relations
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Born at Parkland Hospital
- English or Spanish speaking mother +/- father
- ≤ 30.6 weeks gestation at birth
- Survival to 33 weeks gestation
Exclusion Criteria
- Significant congenital anomalies
- Child Protective Services (CPS) involvement or foster care placement -- Prior enrollment in this PreVNT study for an older sibling.
Recruiting US locations
Parkland Health & Hospital System
Dallas, TX 75235
Site contact: Margaret K Hoge, MD · 405-596-2075 · margaret.hoge@utsouthwestern.edu
Study contacts (from the official record)
- Margaret K Hoge, MD · 214-617-8439 · margaret.hoge@utsouthwestern.edu
- Roy Heyne, MD · roy.heyne@utsouthwestern.edu
Similar studies in Texas
All mental health studies in Texas →- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Richardson, TX + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- DeSoto, TX + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
- Location
- Houston, TX + 1 other US site
- Eligibility basics
- Ages 21–45
- RecruitingHealthy volunteersPhase 1
ACT for Individuals With MNCD and Their Care Partners
Texas Tech University
- Location
- Lubbock, TX
- Eligibility basics
- Ages 18+